Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics

Robert F. Pagels, Robert K. Prud'Homme

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Abstract

Biologically derived therapeutics, or biologics, are the most rapidly growing segment of the pharmaceutical marketplace. However, there are still unmet needs in improving the delivery of biologics. Injectable polymeric nanoparticles and microparticles capable of releasing proteins and peptides over time periods as long as weeks or months have been a major focus in the effort to decrease the frequency of administration. These particle systems fit broadly into two categories: those composed of hydrophilic and those composed of hydrophobic polymeric scaffolds. Here we review the factors that contribute to the slow and controlled release from each class of particle, as well as the effects of synthesis parameters and product design on the loading, encapsulation efficiency, biologic integrity, and release profile. Generally, hydrophilic scaffolds are ideal for large proteins while hydrophobic scaffolds are more appropriate for smaller biologics without secondary structure. Here we also introduce a Flash NanoPrecipitation method that has been adopted for encapsulating biologics in nanoparticles (40-200 nm) at high loadings (50-75 wt.%) and high encapsulation efficiencies. The hydrophilic gel interior and hydrophobic shell provide an opportunity to combine the best of both classes of injectable polymeric depots.

Original languageEnglish (US)
Pages (from-to)519-535
Number of pages17
JournalJournal of Controlled Release
Volume219
DOIs
StatePublished - Dec 10 2015

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Keywords

  • Depot delivery
  • Flash NanoPrecipitation
  • Microparticle
  • Nanoparticle
  • PLGA
  • Protein delivery

Fingerprint Dive into the research topics of 'Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics'. Together they form a unique fingerprint.

Cite this